Acute cannabinoids impair association learning via selectively enhancing synaptic transmission in striatonigral neurons
-
Published:2022-05-13
Issue:1
Volume:20
Page:
-
ISSN:1741-7007
-
Container-title:BMC Biology
-
language:en
-
Short-container-title:BMC Biol
Author:
Wu Meilin,Di Yuanyuan,Diao Zhijun,Yan Chuanting,Cheng Qiangqiang,Huang Huan,Liu Yingxun,Wei Chunling,Zheng Qiaohua,Fan Juan,Han Jing,Liu Zhiqiang,Tian Yingfang,Duan Haijun,Ren Wei,Sun Zongpeng
Abstract
Abstract
Background
Cannabinoids and their derivatives attract strong interest due to the tremendous potential of their psychoactive effects for treating psychiatric disorders and symptoms. However, their clinical application is restricted by various side-effects such as impaired coordination, anxiety, and learning and memory disability. Adverse impact on dorsal striatum-dependent learning is an important side-effect of cannabinoids. As one of the most important forms of learning mediated by the dorsal striatum, reinforcement learning is characterized by an initial association learning phase, followed by habit learning. While the effects of cannabinoids on habit learning have been well-studied, little is known about how cannabinoids influence the initial phase of reinforcement learning.
Results
We found that acute activation of cannabinoid receptor type 1 (CB1R) by the synthetic cannabinoid HU210 induced dose-dependent impairment of association learning, which could be alleviated by intra-dorsomedial striatum (DMS) injection of CB1R antagonist. Moreover, acute exposure to HU210 elicited enhanced synaptic transmission in striatonigral “direct” pathway medium spiny neurons (MSNs) but not indirect pathway neurons in DMS. Intriguingly, enhancement of synaptic transmission that is also observed after learning was abolished by HU210, indicating cannabinoid system might disrupt reinforcement learning by confounding synaptic plasticity normally required for learning. Remarkably, the impaired response-reinforcer learning was also induced by selectively enhancing the D1-MSN (MSN that selectively expresses the dopamine receptor type 1) activity by virally expressing excitatory hM3Dq DREADD (designer receptor exclusively activated by a designer drug), which could be rescued by specifically silencing the D1-MSN activity via hM4Di DREADD.
Conclusion
Our findings demonstrate dose-dependent deleterious effects of cannabinoids on association learning by disrupting plasticity change required for learning associated with the striatal direct pathway, which furthers our understanding of the side-effects of cannabinoids and the underlying mechanisms.
Funder
National Natural Science Foundation of China
Fundamental Research Funds for the Central Universities
Scientific Research Foundation of Shaanxi Normal University grant
Learning Science Interdisciplinary Project of Shaanxi Normal University
Postdoctoral Scientific Research Foundation of Shaanxi Normal University grant
Natural Science Basic Research Plan in Shaanxi Province of China
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Developmental Biology,Plant Science,General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,Physiology,Ecology, Evolution, Behavior and Systematics,Structural Biology,Biotechnology
Reference46 articles.
1. Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, et al. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia. 2014;55:791–802. https://doi.org/10.1111/epi.12631.
2. Ney LJ, Matthews A, Bruno R, Felmingham KL. Cannabinoid interventions for PTSD: where to next? Prog Neuro-Psychopharmacology Biol Psychiatry. 2019;93:124–40. https://doi.org/10.1016/j.pnpbp.2019.03.017.
3. Rey AA, Purrio M, Viveros MP, Lutz B. Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA B receptors in the balance of gabaergic and glutamatergic neurotransmission. Neuropsychopharmacology. 2012;37:2624–34. https://doi.org/10.1038/npp.2012.123.
4. Richards JR. Cannabinoid hyperemesis syndrome: pathophysiology and treatment in the emergency department. J Emerg Med. 2018;54:354–63. https://doi.org/10.1016/j.jemermed.2017.12.010.
5. Akirav I. Cannabinoids and glucocorticoids modulate emotional memory after stress. Neurosci Biobehav Rev. 2013;37:2554–63. https://doi.org/10.1016/j.neubiorev.2013.08.002.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献